Recent

% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

tonasket75 5 posts  |  Last Activity: Aug 21, 2015 4:05 AM Member since: May 27, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • tonasket75 by tonasket75 Aug 21, 2015 4:05 AM Flag

    If this therapy ever makes it to market , or bought out....the market is huge. I have gone long, the potential is so huge , could not help it. Is my go to hell money willing to lose, but I think worth a look. insider taking profits after IPO is normal, good time to buy. Good luck all

    Sentiment: Strong Buy

  • Reply to

    Phase II Completed

    by pinepowderski Aug 6, 2015 2:48 PM
    tonasket75 tonasket75 Aug 19, 2015 1:54 AM Flag

    peanut allergies population is huge ; any FDA approved therapy will go through the roof IMO. I see these patients all the time in the ER. While after recent seel off, I am down , I am hanging on, the potential upside is huge....good luck all....

  • Reply to

    Insurance Coverage

    by subswazus Jul 9, 2015 9:42 AM
    tonasket75 tonasket75 Aug 15, 2015 3:17 AM Flag

    Medicare will cover if baby boomer or prior IV drug use. Medicare does NOT say what test they accept only their criteria. link:
    https://www.hemophilia.org/Newsroom/Advocacy-Legislative-News/CMS-Announces-that-Medicare-Will-Cover-HCV-Screening

    assuming OSUR test is FDA approved, then it should be covered under conditions and age and such above. Now that we have an actual treatment and usual CURE for HCV , I think bodes well for OSUR...
    The "treatment" side of HCV is another discussion. Drugs for roughly 70% cure rate are very expensive. Am sure that discussion will come up in future. (On medicare coverage or not). Given that HCV is known to lead to liver cancer...going to hard for CMS to deny treatment for cure.

  • Reply to

    Insurance Coverage

    by subswazus Jul 9, 2015 9:42 AM
    tonasket75 tonasket75 Aug 15, 2015 2:48 AM Flag

    Great question ; dont know the answer , but it would likely fall under the 30 pages of an insurance policy which wants physicians to limit tests and imaging studies ...unless "medically justified"...
    My guess is (commercial insurance generally follows what Medicare allows as valid testing) is if the patient has risk factors, voices concerns, and since there are now treatments for first time for HCV , that they could not deny payment for rapid HCV . It is a silent killer and leads to liver cancer. Prudent physicians should inquire about risk factors for HCV and if documented in medical record, cant see insurance companies being able to deny test as medically "unnecessary". Esp. now there are a couple drugs on market that have reasonable "cure " rates. HCV is highly associated with liver cancer.
    Great question though, makes a big difference in how this company does in future.

  • Reply to

    Insurance Coverage

    by subswazus Jul 9, 2015 9:42 AM
    tonasket75 tonasket75 Aug 15, 2015 2:39 AM Flag

    are you saying physicians can "diagnose" HIV and HCV based on symptom and physical examination? If so, you are wrong. both HIV and HCV often have no symptoms. Unless one suspects HIV in the acute phase, a viral illness, your assumptions are wrong. Vast Majority of HCV infected patients have NO symptoms. but puts them at much higher risk for Liver Cancer.
    Please clarify what you posted

ABT
45.29-0.73(-1.59%)Aug 31 4:01 PMEDT